Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Biometrics ; h5-index 0.0

Novel biomarkers, in combination with currently available clinical information, have been sought to improve clinical decision making in many branches of medicine, including screening, surveillance, and prognosis. Statistical methods are needed to integrate such diverse information to develop targeted interventions that balance benefit and harm. In the specific setting of disease detection, we propose novel approaches to construct a multiple-marker-based decision rule by directly optimizing a benefit function, while controlling harm at a maximally tolerable level. These new approaches include plug-in and direct-optimization-based algorithms, and they allow for the construction of both nonparametric and parametric rules. A study of asymptotic properties of the proposed estimators is provided. Simulation results demonstrate good clinical utilities for the resulting decision rules under various scenarios. The methods are applied to a biomarker study in prostate cancer surveillance.

Wang Yanqing, Zhao Ying-Qi, Zheng Yingye


biomarker, clinical decision rules, false positive fraction, machine learning, true positive fraction